The efficacy and safety of intra-articular injections with the TNF [tumour necrosis factor]-a antagonist infliximab in patients with chronic or recurrent arthritis of the knee.

Trial Profile

The efficacy and safety of intra-articular injections with the TNF [tumour necrosis factor]-a antagonist infliximab in patients with chronic or recurrent arthritis of the knee.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 23 Sep 2009

At a glance

  • Drugs Infliximab; Methylprednisolone
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Sep 2009 Additional lead trial centre identified, additional trial location (Netherlands) identified as reported by Netherlands Trial Register record.
    • 22 Sep 2009 New source identified and integrated (Netherlands Trial Register).
    • 15 Jul 2009 Results were published in Arthritis and Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top